ai
Anthropic Releases Claude Science Tool for Lab and Drug Research
Anthropic announced Claude Science on Tuesday to optimize its large language model for scientific laboratories and pharmaceutical operations. The company reported $42 billion in annualized sales and a $965 billion valuation last month.
StatAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Anthropic announced the availability of Claude Science on Tuesday, an application that optimizes the company’s large language model for use in scientific laboratories and pharmaceutical research operations, Stat reported. The tool combines more than 60 scientific databases, coding tools, and compute resources. It runs on existing Claude models after biosecurity evaluation.
Anthropic reached annualized sales of $42 billion a month ago, about as much as the drug giant GSK, and holds a valuation of $965 billion based on a $65 billion funding round, far more than any health care company except Eli Lilly, Stat reported. In the last year, Anthropic’s Claude Code application changed the computer programming industry.
Eric Kauderer-Abrams, Anthropic’s head of life sciences, told Stat that the company expects Claude Science to change the life sciences in the same way.
He stated that the company’s efforts in biology are “the single most important thing” at Anthropic. Anthropic is launching pre-clinical drug programs for neglected diseases.
Transparency
How sources framed this
These outlets didn't split into competing frames — coverage was uniform.
CorroborationModerate · 2 sources
